(CGEN) soaring stock after a huge decline in its price. In spite of the tremendous stock decline, Prohost never doubted the fact that Compugen has solid scientific fundamentals and great scientists. The firm has done a great job utilizing its broadly applicable predictive computational discovery ...
screens all candidates for employment to determine if they are currently excluded from participating in federally funded healthcare programs, or have been convicted of a criminal offense related to the provision of healthcare items or services or otherwise related to the responsibilities of the job. ...
New approved indications and massive year-over-year sales growth has Daiichi Sankyo eyeing a year-end pop in sales for its AstraZeneca-partnered cancer drug Enhertu. The Japanese … Sign up to read this article for free. Get free acc...